One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations
- PMID: 38851879
- PMCID: PMC11962909
- DOI: 10.1093/rheumatology/keae323
One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations
Abstract
Objective: To evaluate the effectiveness of long-term, personalized, supervised exercise therapy on functional ability compared with usual care in people with axial spondyloarthritis (axSpA) and severe functional limitations.
Methods: Participants were randomly 1:1 assigned to the intervention [maximal 64 sessions, with 14 additional optional sessions of supervised active exercise therapy (e.g. aerobic and muscle strengthening) with individualized goal-setting, education and self-management regarding physical activity] or usual care (care determined by clinician(s) and participants themselves). Primary endpoint was the change in the Patient-Specific Complaints activity ranked 1 [PSC1 (0-10)] at 52 weeks. Secondary endpoints were the PSC activities ranked 2 and 3, the Bath Ankylosing Spondylitis Functional Index, 6-min walk test, Patient Reported Outcome Measurement Information System-Physical Function-10 and the Short Form-36 Physical and Mental Component Summary Score (SF-36 PCS and MCS). Statistical comparisons comprised independent student t-tests and linear mixed models, based on intention-to-treat.
Results: 214 participants [49% female, age 52 (s.d. 12) years], were randomized to the intervention (n = 110) or usual care (n = 104) group. In the intervention group 93% started treatment, using on average 40.5 sessions (s.d. 15.1). At 52 weeks, the difference in change in PSC1 between groups favoured the intervention group [mean difference (95% CI); -1.8 (-2.4 to -1.2)]. Additionally, all secondary outcomes, except the SF-36 MSC, showed significantly greater improvements in the intervention group with effect sizes ranging from 0.4 to 0.7.
Conclusion: Long-term, supervised exercise therapy proved more effective than usual care in improving functional disability and physical quality of life in people with axSpA and severe functional limitations.
Trial registration: Netherlands Trial Register NL8238, included in the International Clinical Trial Registry Platform (ICTRP) (https://trialsearch.who.int/Trial2.aspx?TrialID=NL8238).
Keywords: exercise; physical function; physical therapy; randomized trial; spondyloarthritis.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.
References
-
- Dougados M, Baeten D.. Spondyloarthritis. Lancet 2011;377:2127–37. - PubMed
-
- Kiltz U, Essers I, Hiligsmann M. et al. Which aspects of health are most important for patients with spondyloarthritis? A best worst scaling based on the ASAS health index. Rheumatology (Oxford) 2016;55:1771–6. - PubMed
-
- National Institute for Health and Care Excellence (NICE). Spondyloarthritis. 2018. https://www.nice.org.uk/guidance/qs170/resources/spondyloarthritis-pdf-7... (27 October 2023, date last accessed). - PubMed
-
- Ramiro S, Nikiphorou E, Sepriano A. et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 2023;82:19–34. - PubMed
-
- Ward MM, Deodhar A, Gensler LS. et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken) 2019;71:1285–99. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
